StudyFinder

MT2013-06C : Treatment of graft Failure after HSCT

Recruiting

The objectives of this study are to assess the following: - Incidence of sustained donor engraftment at day 42 post transplant - Incidence of transplant related mortality (TRM) at day 100 - Overall survival at day 100 and 1 year - Acute GVHD after this second transplant at day 100 and 6 months - Chronic GVHD after this second transplant at day 12 and 24 months

I'm interested

This study is NOT accepting healthy volunteers
Inclusion Criteria:

• patients with primary or secondary HSCT graft failure
• see link to clinicaltrials.gov for complete Inclusion and Exclusion criteria
Exclusion Criteria:

• uncontrolled infection at the time of transplant
• patients with Fanconi Anemia or other DNA breakage syndromes

Drug: Cyclophosphamide, Drug: Fludarabine, Biological: Hematopoietic stem cell infusion, Radiation: Total Body Irradiation

Clinics and Surgery Center (CSC), Failure, Hematopoietic Stem Cell Transplantation, HSCT

Timothy Krepski - tkrepsk1@fairview.org
Troy Lund
1404M49341
15449
See this study on ClinicalTrials.gov

Back